메뉴 건너뛰기




Volumn 64, Issue 3, 2005, Pages 395-401

Coronary complications of percutaneous coronary intervention: A practical approach to the management of abrupt closure

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; WARFARIN;

EID: 14644404275     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20218     Document Type: Review
Times cited : (8)

References (24)
  • 1
    • 0027379976 scopus 로고
    • Guidelines for percutaneous transluminal coronary angioplasty: A report of the AHA/ACC Task Force
    • Ryan TJ, Baumann WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the AHA/ACC Task Force. J Am Coll Cardiol 1993;22:2033-2055.
    • (1993) J Am Coll Cardiol , vol.22 , pp. 2033-2055
    • Ryan, T.J.1    Baumann, W.B.2    Kennedy, J.W.3
  • 2
    • 0026548265 scopus 로고
    • Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile
    • Lincoff AM, Popma JJ, Ellis SG, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;20:926-935.
    • (1992) J Am Coll Cardiol , vol.20 , pp. 926-935
    • Lincoff, A.M.1    Popma, J.J.2    Ellis, S.G.3    Topol, E.J.4
  • 3
    • 0025967094 scopus 로고
    • Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: Frequency, prediction, clinical course, management and follow up
    • de Feyter PJ, van den Brand M, Laarman GH, van Dombud R, Serruys PW, Surypranata H. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, management and follow up. Circulation 1991;83:927-936.
    • (1991) Circulation , vol.83 , pp. 927-936
    • De Feyter, P.J.1    Van Den Brand, M.2    Laarman, G.H.3    Van Dombud, R.4    Serruys, P.W.5    Surypranata, H.6
  • 4
    • 0037012351 scopus 로고    scopus 로고
    • Development of a risk adjustment mortality model using the American College of Cardiology National Cardiovascular Data Registry experience: 1998-2000
    • Shaw RE, Anderson HV, Brindis RG, Krone RJ, Klein LW, McKay CR, Block PC, Shaw LJ, Weintraub WS, on behalf of the ACC-NCDR Development of a risk adjustment mortality model using the American College of Cardiology National Cardiovascular Data Registry experience: 1998-2000. J Am Coll Cardiol 2002;39:1104-1112.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1104-1112
    • Shaw, R.E.1    Anderson, H.V.2    Brindis, R.G.3    Krone, R.J.4    Klein, L.W.5    McKay, C.R.6    Block, P.C.7    Shaw, L.J.8    Weintraub, W.S.9
  • 5
    • 9844266802 scopus 로고    scopus 로고
    • Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial
    • Chaitman BR, Rosen AD, Williams DO, et al. Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial. Circulation 1997;96:162-170.
    • (1997) Circulation , vol.96 , pp. 162-170
    • Chaitman, B.R.1    Rosen, A.D.2    Williams, D.O.3
  • 6
    • 0029155733 scopus 로고
    • Coronary lesions at increased risk
    • Ellis S. Coronary lesions at increased risk. Am Heart J 1995; 130:643-646.
    • (1995) Am Heart J , vol.130 , pp. 643-646
    • Ellis, S.1
  • 9
    • 0036136201 scopus 로고    scopus 로고
    • Evaluation of the Society for Coronary Angiography and Interventions' (SCAI) lesion classification system in 14,133 patients with percutaneous coronary interventions (PCI) in the current stent era
    • Krone RJ, Kimmel SE, Laskey WK, Klein LW, Schechtman KB, Cosentino JJA, Babb JD, Weiner BH, for the Registry Committee of the Society for Cardiac Angiography and Interventions. Evaluation of the Society for Coronary Angiography and Interventions' (SCAI) lesion classification system in 14,133 patients with percutaneous coronary interventions (PCI) in the current stent era. Catheter Cardiovasc Interv 2002:55:1-7.
    • (2002) Catheter Cardiovasc Interv , vol.55 , pp. 1-7
    • Krone, R.J.1    Kimmel, S.E.2    Laskey, W.K.3    Klein, L.W.4    Schechtman, K.B.5    Cosentino, J.J.A.6    Babb, J.D.7    Weiner, B.H.8
  • 10
    • 0041562658 scopus 로고    scopus 로고
    • Evaluation of the ACC/AHA and the SCAI lesion classification system in the current "stent" era of coronary interventions from the ACC-National Cardiovascular Data Registry
    • Krone RJ, Shaw RE, Klein LW, Block PC, Anderson HV, Weintraub WS, Brindis RG, McKay CR, on behalf of the ACC-NCDR. Evaluation of the ACC/AHA and the SCAI lesion classification system in the current "stent" era of coronary interventions from the ACC-National Cardiovascular Data Registry. Am J Cardiol 2003:92:389-394.
    • (2003) Am J Cardiol , vol.92 , pp. 389-394
    • Krone, R.J.1    Shaw, R.E.2    Klein, L.W.3    Block, P.C.4    Anderson, H.V.5    Weintraub, W.S.6    Brindis, R.G.7    McKay, C.R.8
  • 11
    • 14644412129 scopus 로고    scopus 로고
    • Treatment of closure and threatened closure
    • Ellis SG, Holmes DR Jr, editors. Philadelphia: Lippincott Williams and Wilkins
    • Leopold JA, Jacobs AK. Treatment of closure and threatened closure. In: Ellis SG, Holmes DR Jr, editors. Strategic approaches in coronary intervention, 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2000 p 489-501.
    • (2000) Strategic Approaches in Coronary Intervention, 2nd Ed. , pp. 489-501
    • Leopold, J.A.1    Jacobs, A.K.2
  • 12
    • 2242477091 scopus 로고
    • Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
    • EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
    • (1994) N Engl J Med , vol.330 , pp. 956-961
  • 13
    • 1842369101 scopus 로고    scopus 로고
    • Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary intervention
    • EPILOG investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary intervention. N Engl J Med 1997;336:1689-1697.
    • (1997) N Engl J Med , vol.336 , pp. 1689-1697
  • 14
    • 0032508297 scopus 로고    scopus 로고
    • Evaluation of platelet IIb/IIIa inhibitor for stenting: Randomized placebo-controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
    • EPISTENT investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting: randomized placebo-controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
    • (1998) Lancet , vol.352 , pp. 87-92
  • 15
    • 14644445920 scopus 로고    scopus 로고
    • Emergency CABG after failed PCI in contemporary practice: A report from the ACC-NCDR registry
    • Klein LW, Kutcher MA, Block P, Krone R, Weintraub WS, Shaw RE, for the ACC-NCDR registry. Emergency CABG after failed PCI in contemporary practice: a report from the ACC-NCDR registry. J Am Coll Cardiol 2002;39:41A.
    • (2002) J Am Coll Cardiol , vol.39
    • Klein, L.W.1    Kutcher, M.A.2    Block, P.3    Krone, R.4    Weintraub, W.S.5    Shaw, R.E.6
  • 16
    • 85034671315 scopus 로고
    • How does angioplasty work? Serial analysis of human iliac arteries after percutaneous transluminal coronary angioplasty - A quantitative arteriographic analysis
    • Losordo DW, Rosenfield K, Pieczek A, et al. How does angioplasty work? serial analysis of human iliac arteries after percutaneous transluminal coronary angioplasty - a quantitative arteriographic analysis. Circulation 1988;78:1323-1334.
    • (1988) Circulation , vol.78 , pp. 1323-1334
    • Losordo, D.W.1    Rosenfield, K.2    Pieczek, A.3
  • 17
    • 0025902335 scopus 로고
    • Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty
    • Huber MS, Mooney JF, Madison J, Mooney MR. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 1991;68:467-471.
    • (1991) Am J Cardiol , vol.68 , pp. 467-471
    • Huber, M.S.1    Mooney, J.F.2    Madison, J.3    Mooney, M.R.4
  • 18
    • 0025345085 scopus 로고
    • The spectrum of symptomatic coronary air embolism during balloon angioplasty: Causes, consequences, and management
    • Kahn JK, Hartzler GO. The spectrum of symptomatic coronary air embolism during balloon angioplasty: causes, consequences, and management. Am Heart J 1990;119:1374-1377.
    • (1990) Am Heart J , vol.119 , pp. 1374-1377
    • Kahn, J.K.1    Hartzler, G.O.2
  • 20
    • 0032852079 scopus 로고    scopus 로고
    • The significance of creatine kinase release after coronary interventions
    • Klein LW. The significance of creatine kinase release after coronary interventions. Catheter Cardiovasc-Interv 1999;48:130-132.
    • (1999) Catheter Cardiovasc-Interv , vol.48 , pp. 130-132
    • Klein, L.W.1
  • 21
    • 1842293989 scopus 로고    scopus 로고
    • Prognostic implications of creatine kinase elevation following elective coronary interventions
    • Kong TQ, Davidson CJ, Meyers SN, et al. Prognostic implications of creatine kinase elevation following elective coronary interventions. JAMA 1997;227:461-466.
    • (1997) JAMA , vol.227 , pp. 461-466
    • Kong, T.Q.1    Davidson, C.J.2    Meyers, S.N.3
  • 22
    • 0142075775 scopus 로고    scopus 로고
    • Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention
    • Ioannidis JPA, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003; 42:1406-1411.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1406-1411
    • Ioannidis, J.P.A.1    Karvouni, E.2    Katritsis, D.G.3
  • 23
    • 4444251005 scopus 로고    scopus 로고
    • Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation
    • Blankenship JC, Islam MA, Wood GC, Iliadis EA. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation. Catheter Cardiovasc Interv 2004;63:31-41.
    • (2004) Catheter Cardiovasc Interv , vol.63 , pp. 31-41
    • Blankenship, J.C.1    Islam, M.A.2    Wood, G.C.3    Iliadis, E.A.4
  • 24
    • 0032837104 scopus 로고    scopus 로고
    • Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices
    • Kini A, Kini S, Marmur JD, et al. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. Catheter Cardiovasc Interv 1999;48:123-129.
    • (1999) Catheter Cardiovasc Interv , vol.48 , pp. 123-129
    • Kini, A.1    Kini, S.2    Marmur, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.